Table 2 Treatment associations with specific phenotypes (only significant results are displayed).
Treatment, phenotype | Odds IC 95% | p-value |
|---|---|---|
Treatment: mycophenolate, Phenotype: renal | 4.09 (2.20, 7.61) | < 0.001 |
Treatment: mycophenolate, Phenotype: musculoskeletal | 0.43 (0.23, 0.79) | 0.03 |
Treatment: azathioprine, Phenotype: SLEDAI-2K | 0.22 (0.11, 0.44) | < 0.001 |
Treatment: methotrexate, Phenotype: renal | 0.41 (0.19, 0.87) | 0.08 |
Treatment: cyclosporine, Phenotype: heamatological | 2.77 (1.06, 7.23) | 0.14 |
Treatment: cyclosporine, Phenotype: vasculitis | 6.85 (2.35, 19.91) | < 0.001 |
Treatment: methotrexate, Phenotype: musculoskeletal | 4.86 (2.19, 10.79) | < 0.001 |
Treatment: belimumab, Phenotype: musculoskeletal | 1.84 (1.19, 2.83) | 0.03 |
Treatment: belimumab, Phenotype: SLEDAI-2K | 2.03 (1.22, 3.40) | 0.03 |
